跳至主要内容
临床试验/EUCTR2006-004318-42-NL
EUCTR2006-004318-42-NL进行中(未招募)不适用

Influence on brain perfusion and metabolism through pharmacologic agents

Department of Neurology UMCG0 个研究点开始时间: 2006年8月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) a diagnosis of multiple sclerosis according to the McDonald criteria with a secondary progressive disease course and a disease duration of between ten and fifteen years.
  • 2) age of eightteen years or older
  • 3) written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) use of systemic corticosteroids in the eight weeks before the trial
  • 2) use of immunomodulatory treatments for MS
  • 3) a history of cerebral pathology other than MS (cerebral infarct, cerebral haemorrhages, Parkinson's disease, Alzheimer's disease, cerebral vasculitis, brain absces)
  • 4) diabetes mellitus, cardiac arrhythmia, prolonged qt time on ecg, pregnancy or breast-feeding.

研究者

发起方
Department of Neurology UMCG

相似试验

Influence on brain perfusion and metabolism through... | 临床试验